Veradermics
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Veradermics sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Veradermics: 5 sponsored US clinical trials, 1 recruiting.
Veradermics sponsors 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 1 completed. 2 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is AGA, with 4 trials.
Upper-quartile sponsor footprint
Veradermics sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
NCT07146022
Safety and Efficacy of VDPHL01 in Males With AGA
NCT06972264
Efficacy and Safety of VDPHL01 in Males With AGA
NCT06724614
Safety and Efficacy of VDPHL01 in Males and Females With AGA
NCT06527365
Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts
NCT05799157
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 3 | 2 |
Therapeutic Areas
What is open in the Veradermics pipeline
1 recruiting of 5 indexed (20% open); 1 completed (20%).
Phase mix: 2 late (III/IV) vs 3 early (I/II) (balanced across stages).
Top condition: AGA (4 trials), 5 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Veradermics: open-pipeline peers nationwide
Peers matched on 5 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
Veradermics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
- Amazentis · 20% recruiting · 5 trials
Related
What to do with this Veradermics page
5 registered trials is a research-attention snapshot, not an endorsement of Veradermics or any single study.
- 1 of Veradermics's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- AGA is the condition Veradermics studies most, compare against other sponsors active in the same condition before evaluating a specific study. See AGA trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Veradermics pipeline card: 5 registered trials from official public datasets.Report a data error.